The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical CancerO'Sullivan, Ciara; Edgerly, Maureen; Velarde, Margarita; Wilkerson, Julia; Venkatesan, Aradhana M.; Pittaluga, Stefania; Yang, Sherry X.; Nguyen, Dat; Balasubramaniam, Sanjeeve; Fojo, Tito · The Journal of Clinical Endocrinology & Metabolism · 2014

Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid CancerDel Rivero, Jaydira; Edgerly, Maureen; Ward, Jean; Madan, Ravi A.; Balasubramaniam, Sanjeeve; Fojo, Tito; Gramza, Ann W. · The Oncologist · 2018

Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical ChemotherapyJawed, Irfan; Velarde, Margarita; Därr, Roland; Wolf, Katherine I.; Adams, Karen; Venkatesan, Aradhana M.; Balasubramaniam, Sanjeeve; Poruchynsky, Marianne S.; Reynolds, James C.; Pacak, Karel; Fojo, Tito · Cellular and Molecular Neurobiology · 2018

Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lungBalasubramaniam, Sanjeeve; Redon, Christophe E.; Peer, Cody J.; Bryla, Christine; Lee, Min-Jung; Trepel, Jane B.; Tomita, Yusuke; Rajan, Arun; Giaccone, Giuseppe; Bonner, William M.; Figg, William D.; Fojo, Tito; Piekarz, Richard L.; Bates, Susan E. · Anti-Cancer Drugs · 2018